Related Experiment Videos

Potential consequences for recruitment, power, and external validity of requirements for additional risk factors for

Sally C Howard1, Ale Algra, Charles P Warlow

  • 1Department of Clinical Neurology, University of Oxford, United Kingdom.

Stroke
|December 13, 2005
PubMed

Insights

Adding extra eligibility criteria in stroke prevention trials, like vascular risk factors, doesn't significantly boost statistical power. Excluding patients without these factors may harm generalizability and prolong recruitment, making it hard to justify.

Area of Science:

  • Clinical Trials
  • Cardiovascular Research
  • Stroke Prevention

Background:

  • Eligibility criteria in randomized controlled trials (RCTs) impact the generalizability of findings.
  • Recent stroke prevention trials have incorporated additional vascular risk factors to increase outcome events and statistical power.

Purpose of the Study:

  • To evaluate the effectiveness of using additional vascular risk factors as eligibility criteria in stroke prevention trials.
  • To determine if stricter criteria enhance statistical power without compromising generalizability.

Main Methods:

  • Analysis of data from 3 stroke prevention trials and 1 hospital-referred series.
  • Patients with transient ischemic attack or minor ischemic stroke were stratified by two sets of additional risk factors.
  • Calculated risks for stroke, myocardial infarction, or vascular death based on the number of risk factors.

Main Results:

  • Observed risk increased with the number of risk factors (P<0.01).
  • Risks in patients with one or more risk factors were not substantially greater than in all patients.
  • Excluding patients without risk factors could not be statistically justified, despite significant differences in their proportion (21-73%) between criteria sets.

Conclusions:

  • The selection of patients based on additional vascular risk factors can vary significantly between similar criteria sets.
  • The potential for additional criteria to reduce generalizability and extend recruitment outweighs statistical power benefits.
  • Excluding patients without risk factors is difficult to justify due to negative impacts on external validity.
Abstract